Hep A Vaccine May Provide 30 Years of Protection


LONDON - Researchers studying the lasting effects of GlaxoSmithKline's hepatitis A vaccine Havrix say the inoculation may provide 30 years, rather than 10 years, of protection.

Following 155 adults who were vaccinated with Havrix in 1990, the team followed a mathematical formula to determine the protective antibody levels in those vaccinated would remain persistent for 20 to 30 years.

Hepatitis A infection can be contracted by contaminated water or food. Any region of the world without proper sanitation or running water is considered high risk. The virus can cause fever, malaise, jaundice, liver failure and death.

The results of the study were presented at the tenth International Congress on Infectious Diseases in Singapore.

Information from www.givenimaging.com

Related Videos
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
COVID-19 germs, fungi, bacteria objects. (Adobe Stock 584704860 by chawalit)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Related Content